Group structure
6 companies in 3 countries
Loading your page…
Loading your page…
6 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 44
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLARITHROMYCIN1gm | 500mg · Tablet, extended release | Clarithromycin | United States | Marketed | 2004 |
| LANGLARA100units/ml · Injectable | Insulin glargine | United States | Marketed | 2026 |
| SIMPLE GREEN D PRO 3 PLUS1.69 % / w/w + 2.53 % / w/w · Solution, Spray | Benzalkonium, Didecyl dimethyl ammonium | Canada | Marketed | 2019 |
| ARCTOSTAPHYLOS UVA-URSI L. | Brazil | Cancelled | 2002 | |
| B-COMPLEX TAB300 mcg + 40 mg + 0.4 mg + 50 mg + 8.8 mg + 6 mg + 24 mcg + 6.8 mg · Tablet | Biotin, D-pantothenic acid, Folic acid, Nicotinic acid, Vitamin b6, Thiamine mononitrate, Vitamin b12, Vitamin b2 | Canada | Cancelled | 1995 |
| BETA CAROTENE - TAB 25000IU25000 unit / tab · Tablet | Beta-carotene | Canada | Cancelled | 1996 |
| BLG-X70 mg / cap + 30 mg / cap + 85 mg / cap + 71 mg / cap + 55 mg / cap + 64 mg / cap · Capsule | Catnep, Dioscorea villosa, Fennel, Ginger, Peppermint, Viburnum opulus | Canada | Cancelled | 1998 |
| CAL-MAG PLUS VIT D & PHOSPH TAB250 mg / tab + 125 mg / tab + 100 mg / tab + 133 unit / tab · Tablet | Calcium, Magnesium, Phosphorus, Vitamin d | Canada | Cancelled | 1986 |
| CHEWABLE CALCIUM PLUS MAGNESIUM AND MINERALS300 mg / cap + 0.25 mg / cap + 70 mg / cap + 0.5 mg / cap + 2 mg / cap · Tablet | Calcium, Copper, Magnesium, Manganese, Zinc | Canada | Cancelled | 1998 |
| CHI FORMULA4.2 mg · Capsule | Ephedrine | Canada | Cancelled | 1995 |
| CORAL CALCIUM216.7 mg / g · Powder | Calcium | Canada | Cancelled | 2003 |
| ECHINACEA PURPUREA (L.) MOENCH | Brazil | Cancelled | 2002 | |
| F.M. FORMULA80 mg · Capsule | Magnesium | Canada | Cancelled | 1999 |
| FIBRE THREE POWDER 2.4 GM/ 5.0 GM2.4 g / 5 g · Powder | Plantago seed | Canada | Cancelled | 1994 |
| FORMULA S.E.10 mg / cap · Capsule | Ubidecarenone | Canada | Cancelled | 1998 |
| FORMULA VITAMIN C TAB 15MG15 mg / tab · Tablet | Ascorbic acid | Canada | Cancelled | 1995 |
| IMM FORMULA CAP120 mg / cap + 2500 unit / cap + 25 mcg / cap + 2500 unit / cap + 60 unit / cap + 5 mg / cap · Capsule | Ascorbic acid, Beta-carotene, Selenium, Vitamin a, Vitamin e, Zinc | Canada | Cancelled | 1990 |
| LIQUID SILVER3 X · Liquid | Silver | Canada | Cancelled | 2001 |
| MAGNESIUM-TAB250 mg · Tablet | Magnesium | Canada | Cancelled | 1995 |
| MIRABEGRON25mg · Tablet, extended release | Mirabegron | United States | tentative | 2025 |
| MOISTURE LOTION SPF-157.5 % / % + 5 % / % + 1 % / % · Lotion | Octinoxate, Octisalate, Oxybenzone | Canada | Cancelled | 1998 |
| NATRIA-BALANCING DAILY DEFENSE LOTION SPF157.5 % + 3 % · Lotion | Octinoxate, Zinc oxide | Canada | Cancelled | 2003 |
| NATRIA-NOURISHING DAILY DEFENSE LOTION SPF 157.5 % + 3 % · Lotion | Octinoxate, Zinc oxide | Canada | Cancelled | 2003 |
| PASSIFLORA INCARNATA L | Brazil | Cancelled | 2002 | |
| PRO-IMMUNE | Uncaria tomentosa dc. | Brazil | Cancelled | 2002 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 35 | 1 | 34 | CompaniesAll medicines |
| Brazil | 5 | 0 | 5 | CompaniesAll medicines |
| United States | 4 | 2 | 2 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.